Cannaray

Cannaray

Cannaray is a pharmaceutical company that specializes in developing cannabis-based medical drugs. Their drugs are formulated to address debilitating conditions such as chemotherapy-induced nausea, vomiting, multiple sclerosis, epilepsy, and chronic pain. By leveraging the therapeutic power of CBD, Cannaray aims to provide safer and more effective treatment options, thereby improving the quality of life for patients. Through their rigorous scientific research and development efforts, Cannaray is positioned to become a leading player in the emergent field of medical cannabis.

Cannaray's Investors